The FDA-approved type 2 diabetes treatment, Ozempic, which has also found use as a weight loss drug, may have a negative side effect of muscle loss, according to a study published in The Lancet. While the researchers did not advise complete discontinuation of the drug, they recommended strategic use in combination with proper nutrition and exercise to mitigate this side effect.
Botnets leverage decade-old D-Link vulnerabilities in new attack campaigns
A new report from FortiGuard Labs has revealed the activities of two botnets, FICORA and CAPSAICIN, exploiting vulnerabilities in legacy D-Link devices. The report stresses
